CONMED Corp — Director's Dealing 2023

Mar 15, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED Corp (CNMD)
CIK: 0000816956
Period of Report: 2023-03-14

Reporting Person: Hartman Curt R (Director, President, CEO and Chair)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-14	Common Stock	S	5000	$92.8057	Disposed	5299	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	83500	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.76 to $92.92. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.